DE60025494D1 - Epothilon zusammensetzungen - Google Patents

Epothilon zusammensetzungen

Info

Publication number
DE60025494D1
DE60025494D1 DE60025494T DE60025494T DE60025494D1 DE 60025494 D1 DE60025494 D1 DE 60025494D1 DE 60025494 T DE60025494 T DE 60025494T DE 60025494 T DE60025494 T DE 60025494T DE 60025494 D1 DE60025494 D1 DE 60025494D1
Authority
DE
Germany
Prior art keywords
epothilone
compositions
liposomal compositions
provides liposomal
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025494T
Other languages
English (en)
Other versions
DE60025494T2 (de
Inventor
Jean-Claude Sonntag
Markus Wartmann
Karl-Heinz Altmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60025494(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60025494D1 publication Critical patent/DE60025494D1/de
Publication of DE60025494T2 publication Critical patent/DE60025494T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60025494T 1999-08-04 2000-08-02 Epothilon zusammensetzungen Expired - Lifetime DE60025494T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9918429 1999-08-04
GBGB9918429.3A GB9918429D0 (en) 1999-08-04 1999-08-04 Organic compounds
PCT/EP2000/007488 WO2001010412A1 (en) 1999-08-04 2000-08-02 Epothilone compositions

Publications (2)

Publication Number Publication Date
DE60025494D1 true DE60025494D1 (de) 2006-04-06
DE60025494T2 DE60025494T2 (de) 2006-07-27

Family

ID=10858600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025494T Expired - Lifetime DE60025494T2 (de) 1999-08-04 2000-08-02 Epothilon zusammensetzungen

Country Status (8)

Country Link
EP (1) EP1198225B1 (de)
AT (1) ATE315380T1 (de)
AU (1) AU6279500A (de)
DE (1) DE60025494T2 (de)
DK (1) DK1198225T3 (de)
ES (1) ES2254203T3 (de)
GB (1) GB9918429D0 (de)
WO (1) WO2001010412A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
US6893859B2 (en) 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
EP1469847A1 (de) * 2002-01-14 2004-10-27 Novartis AG Kombinationen mit epothilonen und anti-metaboliten
KR20040106422A (ko) * 2002-05-01 2004-12-17 노파르티스 아게 간암 및 다른 암 질병 치료용 에포틸론 유도체
WO2004002468A1 (en) 2002-06-26 2004-01-08 Medigene Oncology Gmbh Method of producing a cationic liposomal preparation comprising a lipophilic compound
WO2004032923A1 (en) * 2002-10-11 2004-04-22 Dana-Farber Cancer Institute Inc Epothilone derivatives for the treatment of multiple myeloma
CA2505368C (en) 2002-11-07 2011-09-20 Kosan Biosciences Incorporated Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
US7691838B2 (en) 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
CN101175489A (zh) 2005-04-29 2008-05-07 高山生物科学股份有限公司 用17-aag或17-ag或其前药治疗多发性骨髓瘤的方法
CA2756499A1 (en) * 2009-03-25 2010-09-30 Novartis Ag Pharmaceutical composition containing a drug and sirna
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis

Also Published As

Publication number Publication date
DE60025494T2 (de) 2006-07-27
AU6279500A (en) 2001-03-05
DK1198225T3 (da) 2006-03-27
WO2001010412A1 (en) 2001-02-15
ES2254203T3 (es) 2006-06-16
GB9918429D0 (en) 1999-10-06
EP1198225B1 (de) 2006-01-11
ATE315380T1 (de) 2006-02-15
EP1198225A1 (de) 2002-04-24

Similar Documents

Publication Publication Date Title
FIC20220041I1 (fi) Voklosporiini
EA199900373A2 (ru) Фармацевтические композиции
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
IT1308627B1 (it) Composizioni fluoroelastomeriche.
IT1308628B1 (it) Composizioni fluoroelastomeriche.
TR199802240T2 (de)
DE60022980D1 (de) Umgerührte Reibschweissverbindungen enthaltendes Bauelement
PT1473036E (pt) Solvato de hemitartarato de zolpidem
NO20023244D0 (no) Hydrogeler
DK1985626T3 (da) P. gingivalis-antigensammensætning
ATE315380T1 (de) Epothilon zusammensetzungen
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
IT1320765B1 (it) Composizione di gomma.
ITTO20020744A1 (it) Composizione.
ITTO990702A0 (it) Composizioni insetticide.
IT1311356B1 (it) Disposizione di macchine.
ITMI20001951A0 (it) Amplificatore di corrente
ITTO20020745A1 (it) Composizione.
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
CY1115144T1 (el) Παραγωγα του uk-2a
HN2000000084A (es) Inhibidores de metaloproteasa.
ES1048844Y (es) Cupon precinto desprendible de cajas de medicamentos.
IT1304174B1 (it) Composizioni perossidiche
FI981420A (fi) Jatkopistokytkin
ITCS990005V0 (it) Sila sorgente di policaretto.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN